newsfilter
← Latest News
Business Wire·

Iveric Bio Announces FDA Has Granted Breakthrough Therapy Designation for Avacincaptad Pegol for Geographic Atrophy

- Designation based on 12-month primary endpoint data from GATHER pivotal trials - - Avacincaptad pegol (ACP) is the only investigational product for treatment of GA to achieve two positive phase 3 pivotal trials with